Fundz

Geron Corporation Appoints Ahmed ElNawawi as Chief Commercial Officer

PUBLIC · GERNOct 13, 2025

Position

Executive Vice President

Company

Geron

Ahmed ElNawawi
Foster CityBiotechnologyHealth Careresearch

Description

Geron Corporation has announced the appointment of Ahmed ElNawawi as Executive Vice President, Chief Commercial Officer, effective October 20, 2025. This transition follows the departure of Jim Ziegler and Andrew Grethlein, who are stepping into consulting roles. The company is enhancing its leadership team to align with its strategic priorities.

Quick answer

Geron Corporation Appoints Ahmed ElNawawi as Chief Commercial Officer (October 13, 2025). Geron is based in Foster City, California, United States.

Who is the new Executive Vice President at Geron?
Geron named Ahmed ElNawawi Executive Vice President, announced October 13, 2025.
What did Geron announce on October 13, 2025?
Geron Corporation has announced the appointment of Ahmed ElNawawi as Executive Vice President, Chief Commercial Officer, effective October 20, 2025. This transition follows the departure of Jim Ziegler and Andrew Grethlein, who are stepping into consulting roles.
What does Geron do?
Geron is a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer.
Where is Geron based?
Geron is based in Foster City, California, United States.
Which similar companies made leadership changes around the same time?
Qpex Biopharma (October 15, 2025), Algorae Pharmaceuticals (October 15, 2025), KalVista Pharmaceuticals (October 6, 2025) and Quotient Therapeutics (October 2, 2025) also announced leadership changes within 45 days of Geron.

Source: Fundz verified event record.

Other recent leadership changes in research and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Geron, and when

A new leader at Geron brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Geron raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Geron, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Geron. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Geron

Location

919 E Hillsdale Blvd

Foster City, California, United States

About

Geron is a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer. Our first-in-class telomerase inhibitor RYTELO® (imetelstat) is approved in the United States and the European Union for the treatment of certain adult patients with lower-risk myelodysplastic syndromes with transfusion dependent anemia. We are also conducting a pivotal Phase 3 clinical trial of imetelstat in JAK-inhibitor relapsed/refractory myelofibrosis, as well as studies in other myeloid hematologic malignancies. Inhibiting telomerase activity, which is increased in malignant stem and progenitor cells in the bone marrow, aims to reduce proliferation and induce death of malignant cells.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Geron changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Dawn
Senior decision-maker at this company
••••••••@••••••••

See Dawn's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Geron's next move

Learn about Strategic plan

Geron changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.